Patents Assigned to Flemington Pharmaceutical Corp.
  • Patent number: 6391282
    Abstract: It has been found that certain antihistamines can mediate the delayed dermatitis and in particular that caused by poison ivy and poison sumac or poison oak. Especially useful are antihistamines having a high degree of intrinsic activity as shown by their low oral dosage as antihistamine (0.1-10, suitably 1-2 mg), which can be topically administered at a sufficiently high active concentration to be effective in the treatment of allergic reactions. Compositions and methods of utilizing such compositions for these purposes are disclosed.
    Type: Grant
    Filed: November 10, 1997
    Date of Patent: May 21, 2002
    Assignee: Flemington Pharmaceutical Corp.
    Inventor: Harry A. Dugger, III
  • Patent number: 5955098
    Abstract: A buccal aerosol spray or capsule using a non-polar solvent has now been developed which provides biologically active compounds for rapid absorption through the oral mucosa, resulting in fast onset of effect. The buccal aerosol spray of the invention comprises formulation I: propellant 50-95%, non-polar solvent 5-50%, active compound 0.001-15%, flavoring agent 00.05-5%. The soft bite gelatin capsule of the invention comprises formulation II: non-polar solvent 55-99.8%, emulsifier 0-20%, active compound 0.001-25%, and flavoring agent 0.05-5.0%.
    Type: Grant
    Filed: April 12, 1996
    Date of Patent: September 21, 1999
    Assignee: Flemington Pharmaceutical Corp.
    Inventor: Harry A. Dugger, III
  • Patent number: 5869082
    Abstract: A buccal aerosol spray using a non-polar solvent has now been developed which provides nitroglycerin for rapid absorption through the oral mucosa, resulting in fast onset of effect. The buccal aerosol spray of the invention comprises: propellant 50-95%, non-polar solvent 5-50%, nitroglycerin 0.001-15%, flavoring agent 0.05-5%.
    Type: Grant
    Filed: April 12, 1996
    Date of Patent: February 9, 1999
    Assignee: Flemington Pharmaceutical Corp.
    Inventor: Harry A. Dugger, III